𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1154 PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT)

✍ Scribed by Romero-Gömez, M.; Planas, R.; Solà, R.; Garcìa-Samaniego, J.; Diago, M.; Crespo, J.; Calleja, J.L.; Turnes, J.


Book ID
122466178
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
54 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Peginterferon alpha-2a is associated wit
✍ Tahany Awad; Kristian Thorlund; Goran Hauser; Davor Stimac; Mahasen Mabrouk; Chr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 1 views

A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin represents the standard of care for the treatment of chronic hepatitis C according to current guidelines. It is not established which of the two licensed products (peginterferon alpha-2a or peginterferon alfa-2b)